MDA-supported researchers have developed a mouse with a mutation in a muscle sodium channel and a disease that mimics human hypokalemic PP
posted on October 14, 2011 - 10:15am
MDA grantee Stephen Cannon at the University of Texas Southwestern Medical Center in Dallas coordinated a study team that has developed a mouse model of one type of hypokalemic periodic paralysis, publishing the development in the Oct. 3, 2011, issue of the Journal of Clinical Investigation.
A phase 3 trial of the drug dichlorphenamide in hyperkalemic and hypokalemic periodic paralysis is open at several U.S. and European centers
posted on October 14, 2011 - 10:13am
A multicenter study of the drug dichlorphenamide in 140 adults with hyperkalemic or hypokalemic periodic paralysis is open at sites in California, Kansas, Massachusetts, Minnesota, Missouri, New York, Ohio and Texas, as well as in France (not yet recruiting), Italy and the United Kingdom.
The conference, Nov. 4-6 in Orlando, Fla., will update families on research and address daily life issues
posted on August 5, 2011 - 3:33pm
The 2011 Periodic Paralysis Association Conference will be held Nov. 4-6 in Orlando, Fla., and is geared toward people with periodic paralysis (PP), their families, physicians and friends.
This is not an MDA meeting, but several current and former MDA research grantees will be speaking. Among them are: